764 related articles for article (PubMed ID: 27760321)
1. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract][Full Text] [Related]
2. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
Yamauchi T
Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
[TBL] [Abstract][Full Text] [Related]
3. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
Wang E; Zhou H; Nadorp B; Cayanan G; Chen X; Yeaton AH; Nomikou S; Witkowski MT; Narang S; Kloetgen A; Thandapani P; Ravn-Boess N; Tsirigos A; Aifantis I
Cell Stem Cell; 2021 Apr; 28(4):718-731.e6. PubMed ID: 33450187
[TBL] [Abstract][Full Text] [Related]
4. Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening.
Tian Z; Octaviani S; Huang J
Expert Opin Ther Targets; 2023; 27(12):1173-1176. PubMed ID: 38069633
[No Abstract] [Full Text] [Related]
5. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
Elife; 2020 Jan; 9():. PubMed ID: 31985402
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
Liu Q; Garcia M; Wang S; Chen CW
Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
[TBL] [Abstract][Full Text] [Related]
7. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens.
Su R; Qing Y; Chen J
Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415
[TBL] [Abstract][Full Text] [Related]
8. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
[TBL] [Abstract][Full Text] [Related]
9. A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.
Hou P; Wu C; Wang Y; Qi R; Bhavanasi D; Zuo Z; Dos Santos C; Chen S; Chen Y; Zheng H; Wang H; Perl A; Guo D; Huang J
Cancer Res; 2017 Aug; 77(16):4402-4413. PubMed ID: 28625976
[TBL] [Abstract][Full Text] [Related]
10. Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
Chen X; Glytsou C; Zhou H; Narang S; Reyna DE; Lopez A; Sakellaropoulos T; Gong Y; Kloetgen A; Yap YS; Wang E; Gavathiotis E; Tsirigos A; Tibes R; Aifantis I
Cancer Discov; 2019 Jul; 9(7):890-909. PubMed ID: 31048321
[TBL] [Abstract][Full Text] [Related]
11. Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.
Prajapati SC; Dunham N; Fan H; Garrett-Bakelman FE
Biotechniques; 2022 Mar; 72(3):81-84. PubMed ID: 35119307
[TBL] [Abstract][Full Text] [Related]
12. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
Bajaj J; Hamilton M; Shima Y; Chambers K; Spinler K; Van Nostrand EL; Yee BA; Blue SM; Chen M; Rizzeri D; Chuah C; Oehler VG; Broome HE; Sasik R; Scott-Browne J; Rao A; Yeo GW; Reya T
Nat Cancer; 2020 Apr; 1(4):410-422. PubMed ID: 34109316
[TBL] [Abstract][Full Text] [Related]
13. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
[TBL] [Abstract][Full Text] [Related]
14. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A; Vasic R; Doench J; Orthwein A; Michor F; Scadden DT
Blood Adv; 2022 Sep; 6(17):5072-5084. PubMed ID: 35793392
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
[TBL] [Abstract][Full Text] [Related]
16. CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy.
Soares F; Chen B; Lee JB; Ahmed M; Ly D; Tin E; Kang H; Zeng Y; Akhtar N; Minden MD; He HH; Zhang L
Blood; 2021 Apr; 137(16):2171-2181. PubMed ID: 33270841
[TBL] [Abstract][Full Text] [Related]
17. Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development.
Arede L; Pina C
Exp Hematol; 2021 Jan; 93():25-37. PubMed ID: 33223444
[TBL] [Abstract][Full Text] [Related]
18. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
Chen C; Liu Y; Rappaport AR; Kitzing T; Schultz N; Zhao Z; Shroff AS; Dickins RA; Vakoc CR; Bradner JE; Stock W; LeBeau MM; Shannon KM; Kogan S; Zuber J; Lowe SW
Cancer Cell; 2014 May; 25(5):652-65. PubMed ID: 24794707
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
[TBL] [Abstract][Full Text] [Related]
20. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
[No Abstract] [Full Text] [Related]
[Next] [New Search]